PharmaLink announced that it started Phase 1 of its expansion project in response to new contracts and increased demand for its reverse distribution services.
The first phase of PharmaLink's expansion project will increase its capacity to 76,000 square feet at its current facility. The company presently leases 51,000 square feet of industrial warehouse space at the Bardmoor Palms Business Park in Largo, Florida, formerly the corporate headquarters of Eckerd Drug. Driven by strong and consistent growth, this investment initiative increases production capacity by 50% and accommodates the company's expanding operations team, which has more than doubled over the past two years.
"The investments we are making in our operations are a strong reflection of PharmaLink's position in the marketplace and positive outlook for the future," said Thierry Beckers, its President & COO. "I'm excited that our team and state-of-the-art facilities are well-positioned to respond to the changing landscape of the healthcare supply chain and the increasing demand for our services and innovative technology."
Once the first phase expansion is complete in March 2020, the company will initiate Phase II, which will include automation, innovative services, and modern facility design, all of which will provide a new paradigm in reverse distribution.